Friday, June 9, 2023
HomeHealth & FitnessFDA approves drug for cats with allergic skin disease

FDA approves drug for cats with allergic skin disease

By Carla Murez

Health Day Reporter

Friday, March 31, 2023 (HealthDay News) — Due to a skin disease called feline atopic dermatitis, cats Constant licking and chewing may benefit from a new generic drug approved by the U.S. Food and Drug Administration.

FDA approved Modulis for cats on March 29, making it the first FDA-approved drug for the skin disease caused by this allergic dermatitis Generic cyclosporine oral solution.

Immunosuppressive drugs suppress the allergic process that causes itching in cats with this disorder.

The drug contains cyclosporine at the same concentration and dose as the approved brand-name drug, Atopica for Cats. The drug was approved in August 2011.

Cats with this condition may be very itchy. They may lick, chew and scratch their skin and hair.

This may cause them to develop other skin problems, including miliary dermatitis, lesions called eosinophilic plaques, and hair loss.

Cats need to be at least 6 months old and weigh 3 lbs to use this medication, which is only available from a veterinarian.

Persons administering this drug to cats should avoid accidental ingestion of the drug. FDA advises not to eat, drink, smoke, or use smokeless tobacco while handling it.

Wash your hands after administering Modulis for Cats to your pet. People with a known allergy to cyclosporine should avoid the product, the FDA warns.

This drug was sponsored by Provetica, LLC of Lenexa, KS. Three sizes.

More info

American Cat The Association of Practitioners has more information on feline allergic dermatitis.

Source: FDA, Press Release, March 29, 2023



Please enter your comment!
Please enter your name here


Featured NEWS